AstraZeneca gets green light for £27.5bn Alexion acquisition
July 14, 2021Research and Development
AstraZeneca has been given the green light of its $39 billion buyout of US-based rare diseases business Alexion by the …
NHS: Cancer backlog to be cleared by March 2022
July 14, 2021Research and Development
NHS chiefs have announced plans to clear the backlog of cancer patients caused by the pandemic by March 2022. Due …
Half the world oblivious to link between oral hygiene and overall health
July 14, 2021Research and Development
A new study from GSK’s consumer healthcare business and Ipsos has shown that half of the world (49%) doesn’t know …
New warning added to J&J vaccine in US
July 13, 2021Manufacturing and Production COVID-19, FDA, J&J, JJ, US, Vaccine
The FDA has made the decision to add a warning to the fact sheet for Johnson & Johnson’s COVID-19 vaccine, …
Scientists develop pain-free ‘holy grail’ sugar test for diabetics
July 13, 2021Manufacturing and Production
Scientists in Australia have developed a non-invasive strip that checks glucose levels through saliva that they say is the ‘holy …
Spanner in the works for Sputnik V as missing data reported
July 13, 2021Manufacturing and Production COVID-19, EMA, Russia, Vaccine
Developers of Russia’s Sputnik V COVID-19 vaccine have repeatedly failed to present data to regulators, Reuters has reported. Five sources …
Scotland approves three new medicines
July 13, 2021Manufacturing and Production
The SMC has approved three new medicines; atezolizumab to treat adult patients with advanced hepatocellular carcinoma (HCC, a type of …
Biogen announces collaboration on novel MS treatment
July 13, 2021Manufacturing and Production multiple sclerosis
Biogen and InnoCare Pharma have announced a license and collaboration agreement for orelabrutinib, an oral small molecule Bruton’s tyrosine kinase …
WHO official condemns lack of masks at Euro finals
July 12, 2021Sales and Marketing
WHO COVID-19 technical lead, Maria Van Kerkhove, has condemned the lack of masks and social distancing at last night’s Euro …
Long COVID: Test may be available within six months
July 12, 2021Sales and Marketing
Researchers from Imperial College London have detected rogue antibodies in the blood of long COVID sufferers, which could lead to …
Janssen & Vor Biopharma to collaborate on acute myeloid leukemia treatment
July 12, 2021Sales and Marketing
Vor Biopharma and Janssen have announced a collaboration to develop engineered hematopoietic stem cell transplants combined with a bi-specific antibody …
FDA acting commissioner seeks review of controversial Alzheimer’s drug approval
July 12, 2021Sales and Marketing
The FDA’s acting commissioner Janet Woodcock is asking for a federal investigation of doctors within her own agency who met …
New data demonstrates extensive activity of Shionogi’s antibiotic cefiderocol
July 12, 2021Sales and Marketing
Shionogi’s novel antibiotic, cefiderocol, has extensive in vitro activity against some of the most difficult to treat carbapenem-resistant Gram-negative bacteria.The …
NICE rejects gene therapy for children with neurodegenerative disorder
July 9, 2021Medical Communications
NICE does not recommend gene therapy OTL-200 (also called Libmeldy and made by Orchard Therapeutics) for treating children with the …
FDA narrows guidance on controversial Alzheimer’s drug
July 9, 2021Medical Communications
A month after the approval of Biogen’s controversial new Alzheimer’s drug, Aduhelm, the FDA has narrowed its guidance on who …
Global genetic exome sequence analysis collaboration announced
July 9, 2021Medical Communications
AbbVie, Pfizer, and Biogen have announced the launch of the world’s largest browsable resource linking rare protein-coding genetic variants to …
Tech successful in harvesting cancer cells in brain metastases patients
July 9, 2021Medical Communications
The University Medical Centre Hamburg-Eppendorf has published results of new work undertaken in patients with brain metastasis using ANGLE’s cell …
Children “extremely low risk” from COVID study finds
July 9, 2021Medical Communications COVID-19, Vaccine
The overall risk of children becoming severely ill or dying from COVID-19 is extremely low, scientists from University College London, …
The pill to be sold over the counter for first time in UK history
July 8, 2021The contraceptive pill will be sold over the counter without prescription for the first time in UK history. The MHRA …
Exscientia receives $1.5 million Gates grant for Covid-19 therapy
July 8, 2021The Oxford-based drugs firm Exscientia has won a $1.5 million grant from the Bill & Melinda Gates Foundation to create …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
